e-learning
resources
Munich 2006
Tuesday 05.09.2006
Pathophysiology and treatment of infections in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinically in-apparent
chlamydia
infections are associated with chronic obstruction and persistent inflammation of peripheral airways (animal model)
J. Jaeger, E. Liebler-Tenorio, N. Kirschvink, G. Becher, F. Melzer, P. Reinhold (Jena, Berlin, Germany; Namur, Belgium)
Source:
Annual Congress 2006 - Pathophysiology and treatment of infections in COPD
Session:
Pathophysiology and treatment of infections in COPD
Session type:
Electronic Poster Discussion
Number:
3377
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Jaeger, E. Liebler-Tenorio, N. Kirschvink, G. Becher, F. Melzer, P. Reinhold (Jena, Berlin, Germany; Namur, Belgium). Clinically in-apparent
chlamydia
infections are associated with chronic obstruction and persistent inflammation of peripheral airways (animal model). Eur Respir J 2006; 28: Suppl. 50, 3377
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013
Chlamydophila
spp. infection in horses with recurrent airway obstruction shows similarities to human chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
Malacia, inflammation and bacterial colonisation of the conducting airways in infants with persistent respiratory symptoms
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
Respiratory viral infections as promoters of allergic sensitization and asthma in animal models
Source: Eur Respir J 2002; 19: 341-349
Year: 2002
Exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 29: 1224-1238
Year: 2007
Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005
Chlamidia infections lead to chronic inflammation in childhood
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008
Airway pathology in asthma
Source: Eur Respir J 2001; 18: 18S-23S
Year: 2001
Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
Mucus production in chronic obstructive lung diseases: relationship with infections
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006
Markers of difference of severe bronchial asthma and chronic obstructive diseases of lungs with irreversible obstruction
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019
b-Lactams and the lung
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=64
Year: 2004
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept